ASML, the Dutch semiconductor lithography maker headquartered in Veldhoven, issued Q2 2026 guidance during its early-May 2026 earnings cycle with a midpoint of €8.7bn, roughly €300m below the analyst consensus of around €9.0bn1. The miss stacks on top of the Q1 2026 result where the Chinese revenue share dropped from 36 per cent to 19 per cent of total sales, a 17 percentage-point compression in a single quarter.
ASML manufactures the EUV (extreme ultraviolet) lithography tools required to produce leading-edge logic chips at sub-7nm process nodes, a capability no other company in the world has commercialised. Its DUV (deep ultraviolet) tools serve the trailing edge, including the older chip production processes Chinese fabs rely on. The DUV revenue from China cross-subsidises EUV development for the rest of the customer base. The Q2 guidance gap of roughly €1.9bn against analyst expectations is a signal of an expectation reset, not a confirmed structural miss; Q2 actuals in late July will resolve direction.
United States export controls set the DUV revenue compression clock; Christophe Fouquet, ASML's CEO, has noted the trajectory in successive earnings cycles without forecasting where it stops. If DUV cash flow thins further through 2026, the EUV R&D budget loses its funding floor without an alternative replacement instrument. Chips Act II's direct-investment authority is Brussels' answer at the fab level rather than at the equipment-maker level. Roger Dassen, ASML's CFO and a member of Mistral's Strategic Committee, sits inside both balance sheets. ASML's actual Q2 numbers in late July will be the first data point on whether the cross-subsidy thesis is holding or breaking.
